Metraipolis › archive › dc_5df86e4b667c

WRN helicase addiction in MSI-H colorectal cancer: biomarker-guided pharmacology, resistance evolution, and implications for other gastrointestinal cancers — Europe PMC PMID:42936277

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42936277
DOI
10.3389/fphar.2026.1962228
License (as archived)
solo-consultazione
Archived
2026-10-31T08:59:11.514Z
SHA-256 of the archived text
2b9c4e2ff66137293936ec3bc7d6ddd8239a8a7ea580f4106104653a935c5035
Stable URL of this page
https://metraipolis.com/documento/dc_5df86e4b667c

How to cite

WRN helicase addiction in MSI-H colorectal cancer: biomarker-guided pharmacology, resistance evolution, and implications for other gastrointestinal cancers — Europe PMC PMID:42936277 — Europe PMC (en), https://europepmc.org/article/MED/42936277 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5df86e4b667c (Metraipolis archive dc_5df86e4b667c, sha256 2b9c4e2ff66137293936ec3bc7d6ddd8239a8a7ea580f4106104653a935c5035)
BibTeX
@misc{dc5df86e4b667c,
  title = {WRN helicase addiction in MSI-H colorectal cancer: biomarker-guided pharmacology, resistance evolution, and implications for other gastrointestinal cancers — Europe PMC PMID:42936277},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42936277},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5df86e4b667c; sha256 2b9c4e2ff66137293936ec3bc7d6ddd8239a8a7ea580f4106104653a935c5035},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42936277. Agents can read the archived copy with the MCP tool read_document.